Saba NF, Wong S, Stokes WA, Rupji M, et al. CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results. Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34701272